Antinuclear antibody in systemic sclerosis (scleroderma). (Q41220132)

28 September 2017

1 reference

title

Antinuclear antibody in systemic sclerosis (scleroderma). (English)

1 reference

28 September 2017

1 reference

Okano Y

1

1 reference

28 September 2017

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

28 September 2017

1 reference

28 September 2017

22

1 reference

28 September 2017

4

1 reference

28 September 2017

709-735

1 reference

Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Disruption of centromere assembly during interphase inhibits kinetochore morphogenesis and function in mitosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anticentromere antibody in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Serological markers in progressive systemic sclerosis: clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anticentromere antibody: an immunological marker of a subset of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Specificity of antinuclear antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

CENP-B: a major human centromere protein located beneath the kinetochore

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

How some T cells escape tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Analysis of the specificity of anti-PM-Scl autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Identification of protein components reactive with anti-PM/Scl autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Immunogenetic associations of scleroderma-related antinuclear antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antibodies in human serum that precipitate ribonuclease P.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Scl 70 antibody--a specific marker of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Nuclear RNase MRP processes RNA at multiple discrete sites: interaction with an upstream G box is required for subsequent downstream cleavages.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Molecular cloning of Xenopus fibrillarin, a conserved U3 small nuclear ribonucleoprotein recognized by antisera from humans with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Human RNaseP RNA and nucleolar 7-2 RNA share conserved 'To' antigen-binding domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anticentromere antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

A human centromere antigen (CENP-B) interacts with a short specific sequence in alphoid DNA, a human centromeric satellite

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Severe systemic sclerosis with anti-topoisomerase I Antibodies is associated with an HLA-DRw11 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Distribution of kinetochore (centromere) antigen in mammalian cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody to centromere (kinetochore) in scleroderma sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Fibrillarin: a new protein of the nucleolus identified by autoimmune sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Purification of the centromere-specific protein CENP-A and demonstration that it is a distinctive histone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

The centromere specific histone CENP-A is selectively retained in discrete foci in mammalian sperm nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Structural analysis of the human U3 ribonucleoprotein particle reveal a conserved sequence available for base pairing with pre-rRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Serological profiles as prognostic clues for progressive systemic scleroderma: the Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Demographic differences in the frequencies of scleroderma-related autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibody to RNA polymerase I in scleroderma sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Characterization and immunolocalization of a nucleolar antigen with anti-NOR serum in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Racial differences in the frequencies of scleroderma-related autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Detection of anticentromere antibodies using cloned autoantigen cenp-Bl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Eukaryotic RNA polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Autoantibodies against RNA polymerase I in scleroderma and Sjögren's syndrome sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Characterization of human MRP/Th RNA and its nuclear gene: full length MRP/Th RNA is an active endoribonuclease when assembled as an RNP

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

A long-term longitudinal study of anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Scl-86, a marker antigen for diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

B cell epitopes on nuclear autoantigens. What can they tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

1 reference

7 January 2021

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

FREQUENCY OF AUTOANTIBODIES TO A MAJOR EPITOPE ON THE CARBOXYL TERMINAL FRAGMENT OF CENP-B IN PATIENTS WITH AUTOIMMUNE DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

Antinuclear antibody with distinct specificity for polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

1 reference

7 January 2021

The 40-kilodalton to autoantigen associates with nucleotides 21 to 64 of human mitochondrial RNA processing/7-2 RNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970297-0

7 January 2021

10.1016/S0889-857X(05)70297-0

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8923592